accountprices.) Rising sales of treatments for mental illness fueled fourth-quarter revenue gains for Bristol-Myers Squibb Co. (BMY) and Eli Lilly & Co. (LLY). Bristol posted a huge fourth-quarter profit from the recent splitting off of its baby-formula...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to 2nd UPDATE: Bristol, Lilly 4Q Sales Up; Resolve Drug Dispute
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account